SHANGHAI HENLIUS BIOTECH
Shanghai Henlius Biotech provides clinical-stage biopharmaceutical services. The company focuses on the development, production and commercialization of mAb biosimilar drugs, bio-betters, and novel mAbs using cutting-edge technology. The company is a joint venture between Shanghai Fosun Pharmaceutical and Henlius Biopharmaceuticals, formed in 2009. It is headquartered in the Shanghai Caohejing High-Technology Park.
SHANGHAI HENLIUS BIOTECH
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2009-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.henlius.com
Total Employee:
101+
Status:
Active
Contact:
021-33395800
Total Funding:
346 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Content Delivery Network Mobile Non Scaleable Content Nginx Euro PHP PHP 7
Similar Organizations
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Frontier Biotechnologies
Frontier Biotechnologies is a commercial-stage bio-pharmaceutical company.
PanTheryx
PanTheryx is a nutrition and biotechnology company that utilizes the cellular and biomolecular processes of bovine colostrum.
Current Employees Featured
Scott Liu Co-Founder & CEO @ Shanghai Henlius Biotech
Co-Founder & CEO
Junli Zhang Vice President and Chief Operating Officer @ Shanghai Henlius Biotech
Vice President and Chief Operating Officer
Weidong Jiang CSO and VP @ Shanghai Henlius Biotech
CSO and VP
Alvin Luk Senior Vice President and Chief Medical Officer @ Shanghai Henlius Biotech
Senior Vice President and Chief Medical Officer
James Guo Vice President and Secretary @ Shanghai Henlius Biotech
Vice President and Secretary
Ping Cao VP of Business Development @ Shanghai Henlius Biotech
VP of Business Development
2018-07-01
Wenjie Zhang President @ Shanghai Henlius Biotech
President
Zidong Zhang Chief Financial Officer @ Shanghai Henlius Biotech
Chief Financial Officer
Timothy Maguire VP, Head of Business Development @ Shanghai Henlius Biotech
VP, Head of Business Development
2022-01-01
Founder
Stock Details
Investors List
CICC
CICC investment in Venture Round - Shanghai Henlius Biotech
New China Capital Management
New China Capital Management investment in Venture Round - Shanghai Henlius Biotech
Green Tomato
Green Tomato investment in Venture Round - Shanghai Henlius Biotech
Loyal Valley Capital
Loyal Valley Capital investment in Venture Round - Shanghai Henlius Biotech
Joyful Ascent
Joyful Ascent investment in Venture Round - Shanghai Henlius Biotech
Green Tomato
Green Tomato investment in Venture Round - Shanghai Henlius Biotech
Fosun Pharma
Fosun Pharma investment in Venture Round - Shanghai Henlius Biotech
ShenZhen GTJA Investment Group
ShenZhen GTJA Investment Group investment in Venture Round - Shanghai Henlius Biotech
Founder H Fund
Founder H Fund investment in Venture Round - Shanghai Henlius Biotech
Korea Investment Partners
Korea Investment Partners investment in Venture Round - Shanghai Henlius Biotech
Official Site Inspections
http://www.henlius.com Semrush global rank: 6.02 M Semrush visits lastest month: 1.36 K
- Host name: 101.132.103.31
- IP address: 101.132.103.31
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "Shanghai Henlius Biotech"
About Henlius-Management Team
Henlius has assembled a team of highly-skilled talents with extensive experience across research & development, clinical ... Senior Vice President and Chief Human Resource Officer, is …See details»
Henlius
Henlius upholds the talent philosophy of "attracting people with visions, engaging people with rewards, cultivating people with challenges and assessing people with performance" and makes great efforts in attracting, empowering, retaining …See details»
About Henlius-Corporate Culture
About Henlius Company Profile Corporate Culture Honor Board of Directors Management Team Advisory Board Product Marketed Products Products in R&D Clinical Trial Science & …See details»
Henlius - LinkedIn
Henlius is a rapidly growing biopharmaceutical provider that develops, manufactures, and distributes leading oncology treatments. Our talented team brings experience from all sectors …See details»
Henlius USA Inc. - LinkedIn
Henlius USA Inc., located in Milpitas, CA, focuses on developing and delivering high-quality, innovative, and affordable medicine to patients worldwide to treat a range of chronic and life ...See details»
Shanghai Henlius Biotech - Crunchbase Company Profile & Funding
Shanghai Henlius Biotech provides clinical-stage biopharmaceutical services. The company focuses on the development, production and commercialization of mAb biosimilar drugs, bio …See details»
Henlius: Culture - LinkedIn
Henlius | 11,714 followers on LinkedIn. Reliable Quality · Affordable Innovation | Henlius is a rapidly growing biopharmaceutical provider that develops, manufactures, and distributes …See details»
HENLIUS USA INC. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for HENLIUS USA INC. of Milpitas, CA. Get the latest business insights from Dun & Bradstreet.See details»
Henlius Biotech shareholders reject take-private offer from China's ...
Jan 22, 2025 Hong Kong shareholders of Shanghai Henlius Biotech on Wednesday rejected Chinese conglomerate Fosun International's buyout offer, which would have valued the …See details»
Investor Relations-Information Disclosure - Henlius
Aug 26, 2024 Henlius 1H21 Results Investor Presentation. 26 March 2021. Henlius 2020 Annual Results. 30 September 2020. Henlius Recent Business Update. 24 August 2020. Henlius …See details»
Henlius - LinkedIn
Henlius | 10,343 followers on LinkedIn. Reliable Quality · Affordable Innovation | Henlius (2696.HK) is a global biopharmaceutical company with the vision to offer high-quality, …See details»
Henlius: using a fully integrated platform to advance high-quality ...
Henlius has submitted two combination clinical programs to run global clinical trials, which pair PD-1 inhibitor HLX10 with HLX04 and HLX07, aiming to achieve synergistic effects by …See details»
Henlius 2025 Company Profile: Stock Performance & Earnings
Henlius has 3,515 total employees. What industry is Henlius in? Henlius’s primary industry is Drug Discovery. Is Henlius a private or public company? Henlius is a Public company. What is …See details»
Shanghai Henlius Biotech - Overview, News & Similar ... - ZoomInfo
Who is Shanghai Henlius Biotech. Henlius (2696.HK) is a global biopharmaceutical company with the vision to offer high-quality, affordable and innovative biologic medicines for pat ients …See details»
Scott Liu - Henlius Biopharmaceuticals - LinkedIn
Experience: Henlius Biopharmaceuticals · Location: Union City · 417 connections on LinkedIn. ... 2025 /PRNewswire/ — CovarsaDx®, a prominent Clinical Research Organization (CRO) …See details»
Henlius
复宏汉霖高效落地全球化战略，携手Abbott, Accord, Dr. Reddy’s, Eurofarma, KGbio, Organon等20余家海外合作伙伴，推动多款产品共触达50余个国家和地区；依托全球临床开发、药政申 …See details»
Biosimilars Forum Welcomes Henlius as Newest Member
December 12, 2024 -The Biosimilars Forum has announced Henlius (2696.HK), a global biopharmaceutical company, as its newest member. Henlius joins the Biosimilars Forum …See details»
Hengenix Biotech - VentureRadar
Hengenix is affiliated with Shanghai Henlius Biotech, a top biopharma company in China co-founded in 2009 by two American biopharmaceutical veterans (Dr. Scott Liu and Dr. Weidong …See details»
Henlius 2021 Annual Results: New Record in Performance, …
In 2021, Henlius’ revenue increased by 186.3% year-on-year (YoY) to RMB 1.68 billion, primarily from sales of various products and licensing revenue.Among them, HANQUYOU (trastuzumab, Zercepac ® in Europe) delivered solid growth in China and Europe, reaching a sales revenue of RMB 868.0 million with a 692.7% YoY increase and RMB 62.2 million from the Chinese …See details»
Henlius 2024 Annual Results: Steady Revenue Growth with a Net …
4 days ago Henlius (2696.HK) is a global biopharmaceutical company with the vision to offer high-quality, affordable and innovative biologic medicines for patients worldwide with a focus …See details»